View ValuationLuminescence Technology 将来の成長Future 基準チェック /06現在、 Luminescence Technologyの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Chemicals 収益成長51.9%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesValuation Update With 7 Day Price Move • May 11Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to NT$53.40, the stock trades at a trailing P/E ratio of 68.8x. Average trailing P/E is 32x in the Chemicals industry in Taiwan. Total returns to shareholders of 252% over the past three years.Valuation Update With 7 Day Price Move • Apr 02Investor sentiment deteriorates as stock falls 22%After last week's 22% share price decline to NT$55.30, the stock trades at a trailing P/E ratio of 78.6x. Average trailing P/E is 27x in the Chemicals industry in Taiwan. Total returns to shareholders of 295% over the past three years.お知らせ • Mar 19Luminescence Technology Corp., Annual General Meeting, Jun 23, 2026Luminescence Technology Corp., Annual General Meeting, Jun 23, 2026. Location: 17- floor no,93, sec.1 hsin t`ai 5th rd., sijhih district, new taipei city TaiwanValuation Update With 7 Day Price Move • Mar 09Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to NT$54.30, the stock trades at a trailing P/E ratio of 77.2x. Average trailing P/E is 22x in the Chemicals industry in Taiwan. Total returns to shareholders of 273% over the past three years.New Risk • Mar 02New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (16% average weekly change). Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Profit margins are more than 30% lower than last year (13% net profit margin). Revenue is less than US$5m (NT$137m revenue, or US$4.4m). Market cap is less than US$100m (NT$1.42b market cap, or US$45.3m).New Risk • Feb 02New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Taiwanese stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Dividend is not well covered by earnings and cash flows. Payout ratio: 135% Cash payout ratio: 135% Minor Risks Profit margins are more than 30% lower than last year (13% net profit margin). Revenue is less than US$5m (NT$137m revenue, or US$4.3m). Market cap is less than US$100m (NT$1.27b market cap, or US$40.2m).Valuation Update With 7 Day Price Move • Feb 02Investor sentiment improves as stock rises 32%After last week's 32% share price gain to NT$48.70, the stock trades at a trailing P/E ratio of 69.2x. Average trailing P/E is 22x in the Chemicals industry in Taiwan. Total returns to shareholders of 250% over the past three years.New Risk • Sep 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 135% Cash payout ratio: 135% Minor Risks Share price has been volatile over the past 3 months (6.6% average weekly change). Profit margins are more than 30% lower than last year (13% net profit margin). Revenue is less than US$5m (NT$137m revenue, or US$4.5m). Market cap is less than US$100m (NT$792.6m market cap, or US$25.8m).Valuation Update With 7 Day Price Move • Sep 02Investor sentiment improves as stock rises 17%After last week's 17% share price gain to NT$34.40, the stock trades at a trailing P/E ratio of 48.9x. Average trailing P/E is 26x in the Chemicals industry in Taiwan. Total returns to shareholders of 139% over the past three years.Reported Earnings • Aug 19First half 2025 earnings released: EPS: NT$0.30 (vs NT$0.29 in 1H 2024)First half 2025 results: EPS: NT$0.30 (up from NT$0.29 in 1H 2024). Revenue: NT$75.3m (up 47% from 1H 2024). Net income: NT$7.55m (up 4.2% from 1H 2024). Profit margin: 10.0% (down from 14% in 1H 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has increased by 17% per year, which means it is well ahead of earnings.Upcoming Dividend • Jul 17Upcoming dividend of NT$0.95 per shareEligible shareholders must have bought the stock before 24 July 2025. Payment date: 16 September 2025. The company is paying out more than 100% of its earnings and cash flow. Trailing yield: 3.7%. Lower than top quartile of Taiwanese dividend payers (5.3%). Higher than average of industry peers (3.1%).Reported Earnings • Jun 04Full year 2024 earnings released: EPS: NT$0.69 (vs NT$1.17 in FY 2023)Full year 2024 results: EPS: NT$0.69 (down from NT$1.17 in FY 2023). Revenue: NT$112.9m (up 13% from FY 2023). Net income: NT$17.4m (down 41% from FY 2023). Profit margin: 15% (down from 29% in FY 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has increased by 7% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • May 07Investor sentiment improves as stock rises 16%After last week's 16% share price gain to NT$25.40, the stock trades at a trailing P/E ratio of 23.2x. Average trailing P/E is 19x in the Chemicals industry in Taiwan. Total returns to shareholders of 57% over the past three years.Valuation Update With 7 Day Price Move • Apr 14Investor sentiment improves as stock rises 15%After last week's 15% share price gain to NT$20.45, the stock trades at a trailing P/E ratio of 18.7x. Average trailing P/E is 18x in the Chemicals industry in Taiwan. Total returns to shareholders of 17% over the past three years.お知らせ • Mar 21Luminescence Technology Corp., Annual General Meeting, Jun 26, 2025Luminescence Technology Corp., Annual General Meeting, Jun 26, 2025. Location: 17- floor no,93, sec.1 hsin t`ai 5th rd., sijhih district, new taipei city TaiwanNew Risk • Mar 03New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 92% Paying a dividend despite having no free cash flows. High level of non-cash earnings (43% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Share price has been volatile over the past 3 months (6.2% average weekly change). Revenue is less than US$5m (NT$104m revenue, or US$3.2m). Market cap is less than US$100m (NT$525.9m market cap, or US$16.0m).New Risk • Jan 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 92% Paying a dividend despite having no free cash flows. High level of non-cash earnings (43% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (6.1% average weekly change). Revenue is less than US$5m (NT$104m revenue, or US$3.2m). Market cap is less than US$100m (NT$592.5m market cap, or US$18.0m).Valuation Update With 7 Day Price Move • Jan 08Investor sentiment improves as stock rises 19%After last week's 19% share price gain to NT$23.40, the stock trades at a trailing P/E ratio of 21.4x. Average trailing P/E is 21x in the Chemicals industry in Taiwan. Total returns to shareholders of 49% over the past three years.Upcoming Dividend • Aug 15Upcoming dividend of NT$1.00 per shareEligible shareholders must have bought the stock before 22 August 2024. Payment date: 16 September 2024. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 4.3%. Lower than top quartile of Taiwanese dividend payers (4.4%). Higher than average of industry peers (2.4%).Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 24%After last week's 24% share price decline to NT$20.30, the stock trades at a trailing P/E ratio of 17.4x. Average trailing P/E is 24x in the Chemicals industry in Taiwan. Total returns to shareholders of 43% over the past three years.Buy Or Sell Opportunity • Jul 08Now 25% overvalued after recent price riseOver the last 90 days, the stock has risen 51% to NT$27.45. The fair value is estimated to be NT$21.89, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 3.7% over the last 3 years. Earnings per share has grown by 25%.Valuation Update With 7 Day Price Move • Jul 02Investor sentiment improves as stock rises 30%After last week's 30% share price gain to NT$24.20, the stock trades at a trailing P/E ratio of 20.8x. Average trailing P/E is 24x in the Chemicals industry in Taiwan. Total returns to shareholders of 71% over the past three years.Reported Earnings • Apr 28Full year 2023 earnings released: EPS: NT$1.16 (vs NT$1.00 in FY 2022)Full year 2023 results: EPS: NT$1.16 (up from NT$1.00 in FY 2022). Revenue: NT$100.3m (down 7.1% from FY 2022). Net income: NT$29.3m (up 16% from FY 2022). Profit margin: 29% (up from 23% in FY 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.お知らせ • Mar 23Luminescence Technology Corp., Annual General Meeting, Jun 27, 2024Luminescence Technology Corp., Annual General Meeting, Jun 27, 2024.Valuation Update With 7 Day Price Move • Mar 21Investor sentiment improves as stock rises 19%After last week's 19% share price gain to NT$19.35, the stock trades at a trailing P/E ratio of 24.6x. Average trailing P/E is 23x in the Chemicals industry in Taiwan. Total returns to shareholders of 34% over the past three years.New Risk • Mar 01New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 190% Cash payout ratio: 169% Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Revenue is less than US$5m (NT$99m revenue, or US$3.1m). Market cap is less than US$100m (NT$412.6m market cap, or US$13.0m).Buy Or Sell Opportunity • Feb 29Now 22% overvaluedOver the last 90 days, the stock has fallen 3.8% to NT$16.40. The fair value is estimated to be NT$13.43, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 9.1% over the last 3 years. Meanwhile, the company has become profitable.Valuation Update With 7 Day Price Move • Aug 24Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to NT$15.10, the stock trades at a trailing P/E ratio of 19.2x. Average trailing P/E is 24x in the Chemicals industry in Taiwan. Total returns to shareholders of 23% over the past three years.Upcoming Dividend • Aug 15Upcoming dividend of NT$1.50 per share at 8.5% yieldEligible shareholders must have bought the stock before 22 August 2023. Payment date: 15 September 2023. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 8.5%. Within top quartile of Taiwanese dividend payers (5.7%). Higher than average of industry peers (3.8%).Buying Opportunity • Jul 04Now 24% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be NT$21.77, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Meanwhile, the company has become profitable.Buying Opportunity • Jun 02Now 22% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be NT$22.06, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Meanwhile, the company has become profitable.Buying Opportunity • May 11Now 21% undervaluedOver the last 90 days, the stock is up 5.8%. The fair value is estimated to be NT$21.99, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Meanwhile, the company has become profitable.Reported Earnings • Apr 30Full year 2022 earnings released: EPS: NT$1.00 (vs NT$0.86 in FY 2021)Full year 2022 results: EPS: NT$1.00 (up from NT$0.86 in FY 2021). Revenue: NT$107.9m (up 3.8% from FY 2021). Net income: NT$25.3m (up 16% from FY 2021). Profit margin: 23% (up from 21% in FY 2021). Over the last 3 years on average, earnings per share has increased by 89% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.Upcoming Dividend • Aug 11Upcoming dividend of NT$0.78 per shareEligible shareholders must have bought the stock before 18 August 2022. Payment date: 08 September 2022. Payout ratio is on the higher end at 90%, however this is supported by cash flows. Trailing yield: 4.5%. Lower than top quartile of Taiwanese dividend payers (6.6%). Lower than average of industry peers (7.9%).Reported Earnings • May 02Full year 2021 earnings released: EPS: NT$0.86 (vs NT$0.23 in FY 2020)Full year 2021 results: EPS: NT$0.86 (up from NT$0.23 in FY 2020). Revenue: NT$104.0m (up 24% from FY 2020). Net income: NT$21.8m (up 268% from FY 2020). Profit margin: 21% (up from 7.0% in FY 2020). The increase in margin was driven by higher revenue.Valuation Update With 7 Day Price Move • Mar 17Investor sentiment improved over the past weekAfter last week's 16% share price gain to NT$23.70, the stock trades at a trailing P/E ratio of 36.3x. Average trailing P/E is 17x in the Chemicals industry in Taiwan. Total returns to shareholders of 39% over the past year.Valuation Update With 7 Day Price Move • Feb 26Investor sentiment improved over the past weekAfter last week's 26% share price gain to NT$23.95, the stock trades at a trailing P/E ratio of 36.7x. Average trailing P/E is 18x in the Chemicals industry in Taiwan. Total returns to shareholders of 91% over the past year.Valuation Update With 7 Day Price Move • Dec 06Investor sentiment improved over the past weekAfter last week's 15% share price gain to NT$20.90, the stock trades at a trailing P/E ratio of 32x. Average trailing P/E is 17x in the Chemicals industry in Taiwan. Total returns to shareholders of 57% over the past year.Reported Earnings • May 02Full year 2020 earnings released: EPS NT$0.24 (vs NT$0.39 loss in FY 2019)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: NT$84.2m (down 2.9% from FY 2019). Net income: NT$5.92m (up NT$15.7m from FY 2019). Profit margin: 7.0% (up from net loss in FY 2019). The move to profitability was driven by lower expenses.分析記事 • Mar 24Luminescence Technology Corp. (GTSM:6729) Investors Should Think About This Before Buying It For Its DividendCould Luminescence Technology Corp. ( GTSM:6729 ) be an attractive dividend share to own for the long haul? Investors...お知らせ • Mar 20Luminescence Technology Corp., Annual General Meeting, Jun 29, 2021Luminescence Technology Corp., Annual General Meeting, Jun 29, 2021.Is New 90 Day High Low • Feb 18New 90-day low: NT$13.15The company is down 7.0% from its price of NT$14.10 on 18 November 2020. The Taiwanese market is up 18% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 5.0% over the same period.Is New 90 Day High Low • Feb 02New 90-day low: NT$13.90The company is down 3.0% from its price of NT$14.30 on 05 November 2020. The Taiwanese market is up 19% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 7.0% over the same period.分析記事 • Dec 10Should You Buy Luminescence Technology Corp. (GTSM:6729) For Its Dividend?Is Luminescence Technology Corp. ( GTSM:6729 ) a good dividend stock? How can we tell? Dividend paying companies with...Is New 90 Day High Low • Oct 21New 90-day high: NT$16.60The company is up 11% from its price of NT$15.00 on 23 July 2020. The Taiwanese market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is down 1.0% over the same period.Is New 90 Day High Low • Sep 24New 90-day low: NT$14.30The company is down 5.0% from its price of NT$15.10 on 24 June 2020. The Taiwanese market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is down 3.0% over the same period. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Luminescence Technology は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測TPEX:6729 - アナリストの将来予測と過去の財務データ ( )TWD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/2025129203434N/A9/30/2025133193027N/A6/30/2025137181820N/A3/31/2025125181924N/A12/31/2024113172028N/A9/30/202410922132N/A6/30/202410427-1936N/A3/31/202410228-1934N/A12/31/202310029-1932N/A9/30/202310025229N/A6/30/202399202227N/A3/31/2023104232933N/A12/31/2022108253539N/A9/30/2022109253639N/A6/30/2022110253740N/A3/31/2022107243639N/A12/31/2021104223538N/A9/30/2021101193135N/A6/30/202197162633N/A3/31/202191112330N/A12/31/20208462126N/A9/30/20208201319N/A6/30/202080-6512N/A3/31/202083-819N/A12/31/201987-10-35N/A9/30/201991-6N/A9N/A6/30/201995-2N/A12N/A3/31/2019981N/A15N/A12/31/20181014N/A19N/A9/30/20181074N/A14N/A6/30/20181133N/A8N/A3/31/20181156N/A-1N/A12/31/20171179N/A-10N/A12/31/201610016N/A14N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 6729の予測収益成長が 貯蓄率 ( 1.3% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: 6729の収益がTW市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: 6729の収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: 6729の収益がTW市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: 6729の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 6729の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/21 11:03終値2026/05/21 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Luminescence Technology Corp. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Valuation Update With 7 Day Price Move • May 11Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to NT$53.40, the stock trades at a trailing P/E ratio of 68.8x. Average trailing P/E is 32x in the Chemicals industry in Taiwan. Total returns to shareholders of 252% over the past three years.
Valuation Update With 7 Day Price Move • Apr 02Investor sentiment deteriorates as stock falls 22%After last week's 22% share price decline to NT$55.30, the stock trades at a trailing P/E ratio of 78.6x. Average trailing P/E is 27x in the Chemicals industry in Taiwan. Total returns to shareholders of 295% over the past three years.
お知らせ • Mar 19Luminescence Technology Corp., Annual General Meeting, Jun 23, 2026Luminescence Technology Corp., Annual General Meeting, Jun 23, 2026. Location: 17- floor no,93, sec.1 hsin t`ai 5th rd., sijhih district, new taipei city Taiwan
Valuation Update With 7 Day Price Move • Mar 09Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to NT$54.30, the stock trades at a trailing P/E ratio of 77.2x. Average trailing P/E is 22x in the Chemicals industry in Taiwan. Total returns to shareholders of 273% over the past three years.
New Risk • Mar 02New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (16% average weekly change). Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Profit margins are more than 30% lower than last year (13% net profit margin). Revenue is less than US$5m (NT$137m revenue, or US$4.4m). Market cap is less than US$100m (NT$1.42b market cap, or US$45.3m).
New Risk • Feb 02New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Taiwanese stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Dividend is not well covered by earnings and cash flows. Payout ratio: 135% Cash payout ratio: 135% Minor Risks Profit margins are more than 30% lower than last year (13% net profit margin). Revenue is less than US$5m (NT$137m revenue, or US$4.3m). Market cap is less than US$100m (NT$1.27b market cap, or US$40.2m).
Valuation Update With 7 Day Price Move • Feb 02Investor sentiment improves as stock rises 32%After last week's 32% share price gain to NT$48.70, the stock trades at a trailing P/E ratio of 69.2x. Average trailing P/E is 22x in the Chemicals industry in Taiwan. Total returns to shareholders of 250% over the past three years.
New Risk • Sep 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 135% Cash payout ratio: 135% Minor Risks Share price has been volatile over the past 3 months (6.6% average weekly change). Profit margins are more than 30% lower than last year (13% net profit margin). Revenue is less than US$5m (NT$137m revenue, or US$4.5m). Market cap is less than US$100m (NT$792.6m market cap, or US$25.8m).
Valuation Update With 7 Day Price Move • Sep 02Investor sentiment improves as stock rises 17%After last week's 17% share price gain to NT$34.40, the stock trades at a trailing P/E ratio of 48.9x. Average trailing P/E is 26x in the Chemicals industry in Taiwan. Total returns to shareholders of 139% over the past three years.
Reported Earnings • Aug 19First half 2025 earnings released: EPS: NT$0.30 (vs NT$0.29 in 1H 2024)First half 2025 results: EPS: NT$0.30 (up from NT$0.29 in 1H 2024). Revenue: NT$75.3m (up 47% from 1H 2024). Net income: NT$7.55m (up 4.2% from 1H 2024). Profit margin: 10.0% (down from 14% in 1H 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has increased by 17% per year, which means it is well ahead of earnings.
Upcoming Dividend • Jul 17Upcoming dividend of NT$0.95 per shareEligible shareholders must have bought the stock before 24 July 2025. Payment date: 16 September 2025. The company is paying out more than 100% of its earnings and cash flow. Trailing yield: 3.7%. Lower than top quartile of Taiwanese dividend payers (5.3%). Higher than average of industry peers (3.1%).
Reported Earnings • Jun 04Full year 2024 earnings released: EPS: NT$0.69 (vs NT$1.17 in FY 2023)Full year 2024 results: EPS: NT$0.69 (down from NT$1.17 in FY 2023). Revenue: NT$112.9m (up 13% from FY 2023). Net income: NT$17.4m (down 41% from FY 2023). Profit margin: 15% (down from 29% in FY 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has increased by 7% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • May 07Investor sentiment improves as stock rises 16%After last week's 16% share price gain to NT$25.40, the stock trades at a trailing P/E ratio of 23.2x. Average trailing P/E is 19x in the Chemicals industry in Taiwan. Total returns to shareholders of 57% over the past three years.
Valuation Update With 7 Day Price Move • Apr 14Investor sentiment improves as stock rises 15%After last week's 15% share price gain to NT$20.45, the stock trades at a trailing P/E ratio of 18.7x. Average trailing P/E is 18x in the Chemicals industry in Taiwan. Total returns to shareholders of 17% over the past three years.
お知らせ • Mar 21Luminescence Technology Corp., Annual General Meeting, Jun 26, 2025Luminescence Technology Corp., Annual General Meeting, Jun 26, 2025. Location: 17- floor no,93, sec.1 hsin t`ai 5th rd., sijhih district, new taipei city Taiwan
New Risk • Mar 03New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 92% Paying a dividend despite having no free cash flows. High level of non-cash earnings (43% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Share price has been volatile over the past 3 months (6.2% average weekly change). Revenue is less than US$5m (NT$104m revenue, or US$3.2m). Market cap is less than US$100m (NT$525.9m market cap, or US$16.0m).
New Risk • Jan 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 92% Paying a dividend despite having no free cash flows. High level of non-cash earnings (43% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (6.1% average weekly change). Revenue is less than US$5m (NT$104m revenue, or US$3.2m). Market cap is less than US$100m (NT$592.5m market cap, or US$18.0m).
Valuation Update With 7 Day Price Move • Jan 08Investor sentiment improves as stock rises 19%After last week's 19% share price gain to NT$23.40, the stock trades at a trailing P/E ratio of 21.4x. Average trailing P/E is 21x in the Chemicals industry in Taiwan. Total returns to shareholders of 49% over the past three years.
Upcoming Dividend • Aug 15Upcoming dividend of NT$1.00 per shareEligible shareholders must have bought the stock before 22 August 2024. Payment date: 16 September 2024. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 4.3%. Lower than top quartile of Taiwanese dividend payers (4.4%). Higher than average of industry peers (2.4%).
Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 24%After last week's 24% share price decline to NT$20.30, the stock trades at a trailing P/E ratio of 17.4x. Average trailing P/E is 24x in the Chemicals industry in Taiwan. Total returns to shareholders of 43% over the past three years.
Buy Or Sell Opportunity • Jul 08Now 25% overvalued after recent price riseOver the last 90 days, the stock has risen 51% to NT$27.45. The fair value is estimated to be NT$21.89, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 3.7% over the last 3 years. Earnings per share has grown by 25%.
Valuation Update With 7 Day Price Move • Jul 02Investor sentiment improves as stock rises 30%After last week's 30% share price gain to NT$24.20, the stock trades at a trailing P/E ratio of 20.8x. Average trailing P/E is 24x in the Chemicals industry in Taiwan. Total returns to shareholders of 71% over the past three years.
Reported Earnings • Apr 28Full year 2023 earnings released: EPS: NT$1.16 (vs NT$1.00 in FY 2022)Full year 2023 results: EPS: NT$1.16 (up from NT$1.00 in FY 2022). Revenue: NT$100.3m (down 7.1% from FY 2022). Net income: NT$29.3m (up 16% from FY 2022). Profit margin: 29% (up from 23% in FY 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.
お知らせ • Mar 23Luminescence Technology Corp., Annual General Meeting, Jun 27, 2024Luminescence Technology Corp., Annual General Meeting, Jun 27, 2024.
Valuation Update With 7 Day Price Move • Mar 21Investor sentiment improves as stock rises 19%After last week's 19% share price gain to NT$19.35, the stock trades at a trailing P/E ratio of 24.6x. Average trailing P/E is 23x in the Chemicals industry in Taiwan. Total returns to shareholders of 34% over the past three years.
New Risk • Mar 01New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 190% Cash payout ratio: 169% Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Revenue is less than US$5m (NT$99m revenue, or US$3.1m). Market cap is less than US$100m (NT$412.6m market cap, or US$13.0m).
Buy Or Sell Opportunity • Feb 29Now 22% overvaluedOver the last 90 days, the stock has fallen 3.8% to NT$16.40. The fair value is estimated to be NT$13.43, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 9.1% over the last 3 years. Meanwhile, the company has become profitable.
Valuation Update With 7 Day Price Move • Aug 24Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to NT$15.10, the stock trades at a trailing P/E ratio of 19.2x. Average trailing P/E is 24x in the Chemicals industry in Taiwan. Total returns to shareholders of 23% over the past three years.
Upcoming Dividend • Aug 15Upcoming dividend of NT$1.50 per share at 8.5% yieldEligible shareholders must have bought the stock before 22 August 2023. Payment date: 15 September 2023. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 8.5%. Within top quartile of Taiwanese dividend payers (5.7%). Higher than average of industry peers (3.8%).
Buying Opportunity • Jul 04Now 24% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be NT$21.77, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Meanwhile, the company has become profitable.
Buying Opportunity • Jun 02Now 22% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be NT$22.06, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Meanwhile, the company has become profitable.
Buying Opportunity • May 11Now 21% undervaluedOver the last 90 days, the stock is up 5.8%. The fair value is estimated to be NT$21.99, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Meanwhile, the company has become profitable.
Reported Earnings • Apr 30Full year 2022 earnings released: EPS: NT$1.00 (vs NT$0.86 in FY 2021)Full year 2022 results: EPS: NT$1.00 (up from NT$0.86 in FY 2021). Revenue: NT$107.9m (up 3.8% from FY 2021). Net income: NT$25.3m (up 16% from FY 2021). Profit margin: 23% (up from 21% in FY 2021). Over the last 3 years on average, earnings per share has increased by 89% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.
Upcoming Dividend • Aug 11Upcoming dividend of NT$0.78 per shareEligible shareholders must have bought the stock before 18 August 2022. Payment date: 08 September 2022. Payout ratio is on the higher end at 90%, however this is supported by cash flows. Trailing yield: 4.5%. Lower than top quartile of Taiwanese dividend payers (6.6%). Lower than average of industry peers (7.9%).
Reported Earnings • May 02Full year 2021 earnings released: EPS: NT$0.86 (vs NT$0.23 in FY 2020)Full year 2021 results: EPS: NT$0.86 (up from NT$0.23 in FY 2020). Revenue: NT$104.0m (up 24% from FY 2020). Net income: NT$21.8m (up 268% from FY 2020). Profit margin: 21% (up from 7.0% in FY 2020). The increase in margin was driven by higher revenue.
Valuation Update With 7 Day Price Move • Mar 17Investor sentiment improved over the past weekAfter last week's 16% share price gain to NT$23.70, the stock trades at a trailing P/E ratio of 36.3x. Average trailing P/E is 17x in the Chemicals industry in Taiwan. Total returns to shareholders of 39% over the past year.
Valuation Update With 7 Day Price Move • Feb 26Investor sentiment improved over the past weekAfter last week's 26% share price gain to NT$23.95, the stock trades at a trailing P/E ratio of 36.7x. Average trailing P/E is 18x in the Chemicals industry in Taiwan. Total returns to shareholders of 91% over the past year.
Valuation Update With 7 Day Price Move • Dec 06Investor sentiment improved over the past weekAfter last week's 15% share price gain to NT$20.90, the stock trades at a trailing P/E ratio of 32x. Average trailing P/E is 17x in the Chemicals industry in Taiwan. Total returns to shareholders of 57% over the past year.
Reported Earnings • May 02Full year 2020 earnings released: EPS NT$0.24 (vs NT$0.39 loss in FY 2019)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: NT$84.2m (down 2.9% from FY 2019). Net income: NT$5.92m (up NT$15.7m from FY 2019). Profit margin: 7.0% (up from net loss in FY 2019). The move to profitability was driven by lower expenses.
分析記事 • Mar 24Luminescence Technology Corp. (GTSM:6729) Investors Should Think About This Before Buying It For Its DividendCould Luminescence Technology Corp. ( GTSM:6729 ) be an attractive dividend share to own for the long haul? Investors...
お知らせ • Mar 20Luminescence Technology Corp., Annual General Meeting, Jun 29, 2021Luminescence Technology Corp., Annual General Meeting, Jun 29, 2021.
Is New 90 Day High Low • Feb 18New 90-day low: NT$13.15The company is down 7.0% from its price of NT$14.10 on 18 November 2020. The Taiwanese market is up 18% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 5.0% over the same period.
Is New 90 Day High Low • Feb 02New 90-day low: NT$13.90The company is down 3.0% from its price of NT$14.30 on 05 November 2020. The Taiwanese market is up 19% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 7.0% over the same period.
分析記事 • Dec 10Should You Buy Luminescence Technology Corp. (GTSM:6729) For Its Dividend?Is Luminescence Technology Corp. ( GTSM:6729 ) a good dividend stock? How can we tell? Dividend paying companies with...
Is New 90 Day High Low • Oct 21New 90-day high: NT$16.60The company is up 11% from its price of NT$15.00 on 23 July 2020. The Taiwanese market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is down 1.0% over the same period.
Is New 90 Day High Low • Sep 24New 90-day low: NT$14.30The company is down 5.0% from its price of NT$15.10 on 24 June 2020. The Taiwanese market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is down 3.0% over the same period.